Venlafaxine Hydrochloride
Product Images NDC 45865-643

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 45865-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp37.5 (643 60)

Venlafaxine Hydrochloride extended-release capsules 37.5 mg, generic for Effexor XR, labeled by Medsource Pharmaceuticals. The label indicates a quantity of 60 capsules per package. It includes lot number and NDC information, dosage warnings, and instructions to take with food and avoid alcohol.*

FDA Label Image

Pdp75 (647 60)

Venlafaxine HCl ER Capsules 75mg carton label showing product name, strength, generic indication for Effexor XR, and quantity of 60 capsules. The label includes warnings for dizziness, drowsiness, and alcohol avoidance in English and Spanish, along with instructions to take as directed by a physician. Manufacturer listed is Medsource Pharmaceuticals.*

FDA Label Image

Figure1 (Figure1)

A dot plot chart depicting the pharmacokinetic fold change and 90% confidence intervals for venlafaxine analytes (cmax, AUC, OD) in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The chart shows changes relative to a reference value with recommendations on dose adjustments or cautions for each interacting drug.*

FDA Label Image

Figure2 (Figure2)

A chart showing pharmacokinetic fold changes and 90% confidence intervals for various interacting drugs with Venlafaxine Hydrochloride. The x-axis represents change relative to the reference value, with points plotted for analytes and PKFold changes, and corresponding clinical recommendations like dose adjustments or monitoring instructions listed.*

FDA Label Image

Figure3 (Figure3)

A scatter plot chart showing fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for venlafaxine hydrochloride in various special populations including hepatic impairments, renal impairments, CYP2D6 polymorphism, age over 60, and gender. The x-axis represents change relative to a reference value, with dose adjustment recommendations listed for each population group.*

FDA Label Image

Structure (Structure)

Chemical structure of venlafaxine hydrochloride displayed with molecular components, including a cyclohexane ring, methoxyphenyl group, and dimethylamine moiety, labeled clearly under the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.